| 产品编号 | D51186 |
| 英文名称 | Varenicline |
| 中文名称 | |
| 别 名 | α4β2 nAChR/α7 nAChR/α3β4 nAChR激动剂 |
| 克 隆 号 | |
| CAS | 249296-44-4 |
| 理论分子量 | 211.26 kDa |
| 检测分子量 | |
| 性 状 | Lyophilized |
| 保存条件 | Store in dry, dark place for one year. |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
Varenicline is a nicotinic receptor partial agonist—it stimulates nicotine receptors more weakly than nicotine itself does. In this respect it is similar to cytisine and different from the nicotinic antagonist, bupropion, and nicotine replacement therapies (NRTs) like nicotine patches and nicotine gum. Varenicline displays full agonism on α7 nicotinic acetylcholine receptors and is a partial agonist on the α4β2, α3β4, and α6β2 subtypes. In addition, it is a weak agonist on the α3β2 containing receptors. Varenicline's partial agonism on the α4β2 receptors rather than nicotine's full agonism produces less effect of dopamine release than nicotine's. This α4β2 competitive binding reduces the ability of nicotine to bind and stimulate the mesolimbic dopamine system—similar to the method of action of buprenorphine in the treatment of opioid addiction. CAS：249296-44-4 分子式：C13H13N3 分子量：211.26 MDL：MFCD10001497 纯度：≥99.5% (HPLC) 作用靶点：nAChR; 作用通路：Membrane Transporter/Ion Channel; Neuronal Signaling； 产品描述：伐伦克林 (Varenicline) 是 α4β2 nAChR 烟碱乙酰胆碱受体的一个部分激动剂 (EC50=2.3 μM)。Varenicline 是 α3β4 nAChR 和 α7 nAChR 乙酰胆碱受 |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |
